PrenaTest™ is a third generation DNAscreening test forprenatal diagnosis of Down’s syndrome, Edward’s syndrome, and Patau’s syndrome (Trisomies 21, 18, and 13) in the first trimester.
There are various ways that the physicians, tracing the course of your pregnancy, may use to check the health status of your unborn child. This website is dedicated to an absolutely safe and painless blood test that could be done at a very early stage of your pregnancy. PrenaTest™ is a contemporary third-generation DNA test that allows for determining whether you are at risk of having a baby with Down’s syndrome, Patau’s syndrome or Edward’s syndrome as early as the beginning of the 9thweek of pregnancy.
PrenaTest™ does not represent a definitive diagnosis, yet it allows for determining with maximum degree of accuracy (>99%) whether your unborn baby is at a high risk of being affected by the most common congenital genetic abnormalities.
The greatest PRO for the PrenaTest™ is that it is not an invasive test. This means that no biological material has to be taken for this test either from the placenta or from the amniotic fluid, unlike the alternative methods such as amniocentesis and chorionic villus sampling that are associated with a substantial risk of complications and even of miscarriage. Quick andstress-free, the prenatal screening test PrenaTest™ only requires taking of venous blood from the mother.
If you are interested in the PrenaTest®, please ask your attending gynaecologist as early as the first visits.Then you can contact us and we shall refer you for blood sampling to a medical centre or a laboratory that is most convenient for you to visit.
Advantages of the PrenaTest™
Обработка и анализ – какво се случва в лабораторията на PrenaTest™
The DNA prenatal test PrenaTest™ can provide you with very useful information about your pregnancy. Yet, it is essential that you understand that this is a screening test, and not a definitive diagnosis of the health status of your unborn baby. You will not get the results from us – they will be sent to your responsible gynaecologist or specialist in genetics. They are the only persons, who can make the final diagnosis, most oftensupported by the findings of additional examinationsthat they at their discretion will refer you to perform.
The following diagnostic testscan determine with absolute certaintywhether your pregnancy is associated with Down’s syndrome, trisomy 13 and 18, or with other chromosomal abnormality. They, however, carry the risk of additional complications for the pregnancy or of miscarriage.
Amniocentesis: This is a medical procedure during which the physician inserts a fine needle in the mother’s uterus. A small amount of amniotic fluid (the fluid surrounding the baby) is extracted for analysis. The procedure is usually done when a woman is between 16 and 18 weeks pregnant and is associated with miscarriage risk of about 1%.
Chorionic villus sampling: This medical procedure is related to sampling of a small tissue amount of the exterior wall of the placenta. This tissue can then be tested for chromosomal abnormalities. It can becarried out not earlier than the 12th week of pregnancy and is associated with a miscarriage risk of about 3-5%.